Eurogin 2011
May 8-11, 2011
Lisbon, Portugal
IncellDx will be a Silver Sponsor at Eurogin 2011!
The conference aims at developing a full review of current scientific developments in the field of cervical cancer control and beyond, including vulvar, anal and head & neck HPV associated diseases. The event will highlight recent advances, and provide a forum for exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination.
AMP 2010 Annual Meeting
November 17-20, 2010
San Jose, CA
IncellDx will be an exhibitor at AMP 2010.
The four-day event will feature three days of cutting-edge lectures and workshops, as well as Corporate exhibits, working lunch meetings, and casual social gatherings offering opportunities for networking and further exchange with molecular laboratory professionals.
26th International Human Papillomavirus Conference
July 3-8, 2010
Montreal, Canada
IncellDx is a proud sponsor at the 26th International Papillomavirus Conference and Clinical and Public Health Workshop, being held in Montreal, Canada July 3-8 at the Palais des Congres. Find us at Booth 18 where we will be featuring our novel products and platforms ffor detections of E6, E7 mRNA in each and every cell.
IncellDx’s CEO and Founder, Dr. Bruce Patterson will be presenting on Tuesday July 6 at 3pm: “Cell by Cell Quantification of HPV E6/E7 mRNA Expression Increases the Positive Predictive Value of Cervical Cancer Screening”
Clinical Sciences Poster:
Intracellular HPV E6, E7 mRNA quantification predicts CIN 2, 3 in biopsies better than Pap screening.
ASCCP Biennial Meeting
March 24-27, 2010
Green Valley Ranch Resort in Las Vegas, Nevada
IncellDx will be exhibiting at the 2010 American Society for Colposcopy and Cervical Pathology Biennial Meeting.
Eurogin 2010
February 17-20, 2010
Monte – Carlo, Monaco
Three scientific abstracts featuring IncellDx products have been accepted for oral presentation at the EUROGIN 2010 Congress. IncellDx is a bronze sponsor of the Congress and will have an exhibit booth (T8).
IncellDx’s presentations on Saturday, February 20, 9:30am – 12:30pm include:
- Intracellular HPV E6, E7 mRNA quantification (OncoTect) predicts CIN 2/3 in biopsies better than pap screening for women regardless of age, Bosio Room – D. Pierry
- Downregulation of E6, E7 mRNA in cervical cancer cells by leukemia inhibitory facor (LIF) quanti ed using HPV OncoTect, Poulenc Room – B. Patterson
- Quanti fication of intracellular HPV E6/E7 mRNA expression increases the positive predictive value of cervical cancer screening, Bosio Room – B. Patterson
